| Authors: |
Werth K; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany., Hub E; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, EC1M 6BQ London, UK; Centre for Inflammation and Therapeutic Innovation, Queen Mary University London, EC1M 6BQ London, UK., Gutjahr JC; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, EC1M 6BQ London, UK., Bosjnak B; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany., Zheng X; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany., Bubke A; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany., Russo S; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, EC1M 6BQ London, UK., Rot A; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, EC1M 6BQ London, UK; Centre for Inflammation and Therapeutic Innovation, Queen Mary University London, EC1M 6BQ London, UK; Institute for Cardiovascular Prevention, Ludwig-Maximilians University, 80336 Munich, Germany. Electronic address: a.rot@qmul.ac.uk., Förster R; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625 Hannover, Germany. Electronic address: foerster.reinhold@mh-hannover.de. |
